Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing and Detection During Peripartum Hospitalizations Among a Multicenter Cohort of Pregnant Persons: March 2020–February 2021
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciac657 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Miranda J Delahoy und 21 weiteren Autor:innen. Beteiligte Einrichtung: COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: COVID-19, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CDC HHS, Centers for Disease Control and Prevention, Abt Associates.
Abstract (Originalsprache)
Background
Identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during peripartum hospitalizations is important to guide care, implement prevention measures, and understand infection burden.
Methods
This cross-sectional analysis used electronic health record data from hospitalizations during which pregnancies ended (peripartum hospitalizations) among a cohort of pregnant persons at 3 US integrated healthcare networks (sites 1–3). Maternal demographic, medical encounter, SARS-CoV-2 testing, and pregnancy and neonatal outcome information was extracted for persons with estimated delivery and pregnancy end dates during March 2020–February 2021 and ≥1 antenatal care record. Site-stratified multivariable logistic regression was used to identify factors associated with testing and compare pregnancy and neonatal outcomes among persons tested.
Results
Among 17 858 pregnant persons, 10 863 (60.8%) had peripartum SARS-CoV-2 testing; 222/10 683 (2.0%) had positive results. Testing prevalence varied by site and was lower during March–May 2020. Factors associated with higher peripartum SARS-CoV-2 testing odds were Asian race (adjusted odds ratio [aOR]: 1.36; 95% confidence interval [CI]: 1.03–1.79; referent: White) (site 1), Hispanic or Latino ethnicity (aOR: 1.33; 95% CI: 1.08–1.64) (site 2), peripartum Medicaid coverage (aOR: 1.33; 95% CI: 1.06–1.66) (site 1), and preterm hospitalization (aOR: 1.69; 95% CI: 1.19–2.39 [site 1]; aOR: 1.39; 95% CI: 1.03–1.88 [site 2]).
Conclusions
Findings highlight potential disparities in SARS-CoV-2 peripartum testing by demographic and pregnancy characteristics. Testing practice variations should be considered when interpreting studies relying on convenience samples of pregnant persons testing positive for SARS-CoV-2. Efforts to address testing differences between groups could improve equitable testing practices and care for pregnant persons with SARS-CoV-2 infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Baylor College of Medicine, Houston, Texas, USA.
- Kaiser Permanente Northern California, Oakland, California, USA.
- Abt Associates, Rockville, Maryland, USA.
- Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
ORCID-Profile: Miranda J Delahoy
Förderung
- CDC HHS
- Centers for Disease Control and Prevention
- Abt Associates
Zitieren
APA
Delahoy, M. J., Munoz, F., Li, D. K., Arriola, C. S., Bond, N. L., Daugherty, M., Ferber, J., Ferguson, N., Hadden, L., Henderson, J. T., Irving, S. A., Juergens, M., Kancharla, V., Greenberg, M., Odouli, R., Newes-Adeyi, G., Nicholson, E. G., Reichle, L., Sanyang, M., …, & Naleway, A. L. (2023). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing and Detection During Peripartum Hospitalizations Among a Multicenter Cohort of Pregnant Persons: March 2020–February 2021. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac657
Vancouver
Delahoy MJ, Munoz F, Li DK, Arriola CS, Bond NL, Daugherty M, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing and Detection During Peripartum Hospitalizations Among a Multicenter Cohort of Pregnant Persons: March 2020–February 2021. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac657
BibTeX
@article{Delahoy2023,
author = {Delahoy, Miranda J and Munoz, Flor and Li, De-Kun and Arriola, Carmen Sofia and Bond, Nanette Lee and Daugherty, Michael and Ferber, Jeannette and Ferguson, Nickolas and Hadden, Louise and Henderson, Jillian T and Irving, Stephanie A and Juergens, Mary and Kancharla, Venkatesh and Greenberg, Mara and Odouli, Roxana and Newes-Adeyi, Gabriella and Nicholson, Erin G and Reichle, Lawrence and Sanyang, Momodou and Snead, Margaret and Dawood, Fatimah S and Naleway, Allison L},
title = {Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing and Detection During Peripartum Hospitalizations Among a Multicenter Cohort of Pregnant Persons: March 2020–February 2021},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciac657}
}
EUVIMED